Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical ...

Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities research analysts at William ...

Animal rights advocates are hoping a recent recommendation by the secretariat of an international trade agreement will push the Canadian government to halt imports of endangered monkeys from Cambodia ...

Life sciences stocks were in retreat Thursday after the news outlet Science reported that newly imposed restrictions on the National Institutes of Health by the Trump administration have stoked ...

Analysts have recently evaluated Charles River and provided 12-month price targets. The average target is $214.5, accompanied by a high estimate of $250.00 and a low estimate of $185.00. A 2.72% drop ...